RedHill Biopharma
Manufacturing · North Carolina, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
8311 Brier Creek Pkwy Ste 105-161, Ralei...Phone Number
(984) 444-7010Website
www.redhillbio.comRevenue
$9.6 MillionStock Symbol
RDHLIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About RedHill Biopharma
Founded in 2009, RedHill Biopharma is a specialty biopharmaceutical company, primarily focused on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. The company is headquartered in Tel Aviv, Isreal.Explore more
RedHill Biopharma Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is RedHill Biopharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if RedHill Biopharma has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at RedHill Biopharma
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on RedHill Biopharma recently announced quarterly report
Click to see if RedHill Biopharma had a recent Job posting/layoffs
RedHill Biopharma, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when RedHill Biopharma launches new products
Funding: Get notified immidiatlly once RedHill Biopharma has new funding data
Check out if RedHill Biopharma is spiking on competitors!
Recommended Actions
Find VP level buyers at RedHill Biopharma
Find 3 more new buyers
Company Profile Activity
Activity Insights
RedHill Biopharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
RedHill Biopharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about RedHill Biopharma.
RedHill Biopharma financials insights
Gather financial insights about RedHill Biopharma, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$2M
RedHill Biopharma Tech Stack
A closer look at the technologies used by RedHill Biopharma
See more technologies
Most Recent Scoops
Person-Based
Medical Research, Pharmaceuticals
Person-Based
Lawsuits, Legal Affairs
Person-Based
Person-Based
Pharmaceuticals
Person-Based
Pharmaceuticals
RedHill Biopharma News & Media
RedHill Biopharma Announces Closing of Up To $19.4 Million Private Placement
$6 million upfront with up to approximately $13.4 million of potential aggregate gross proceeds upon the exercise in full of warrants TEL AVIV, Israel and RALEIGH, N.C., June 22, 2026 /PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty...RedHill Biopharma Announces Up To $19.4 Million Private Placement
$6 million upfront with up to approximately $13.4 million of potential aggregate gross proceeds upon the exercise in full of warrants TEL AVIV, Israel & RALEIGH, N.C., June 18, 2026 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty...RedHill's Opaganib Receives FDA Rare Pediatric Disease Designation for Neuroblastoma in Addition to Current Orphan Drug Designation
The U.S. Food and Drug Administration (FDA) has granted rare pediatric disease designation to opaganib1 for the treatment of neuroblastoma, a type of cancer most commonly affecting babies and young children -- Rare pediatric disease designation provides for a Priority Review Voucher (PRV)...RedHill Launches Enforcement of $11 Million New York Supreme Court Final Judgment Against Kukbo
RALEIGH, N.C. and TEL-AVIV, Israel, June 8, 2026 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that it has commenced recognition and enforcement proceedings in Korea in respect of the New York...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding RedHill Biopharma
Sign Up For FreeTo access detailed company insights
Founded in 2009, RedHill Biopharma is a specialty biopharmaceutical company, primarily focused on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo... Read More
